Safety and Efficacy of 188-Rhenium-Labeled Antibody to Melanin in Patients with Metastatic Melanoma
There is a need for effective “broad spectrum” therapies for metastatic melanoma which would be suitable for all patients. The objectives of Phase Ia/Ib studies were to evaluate the safety, pharmacokinetics, dosimetry, and antitumor activity of 188Re-6D2, a 188-Rhenium-labeled antibody to melanin. S...
Main Authors: | M. Klein, M. Lotem, T. Peretz, S. T. Zwas, S. Mizrachi, Y. Liberman, R. Chisin, J. Schachter, I. G. Ron, G. Iosilevsky, J. A. Kennedy, E. Revskaya, A. W. de Kater, E. Banaga, V. Klutzaritz, N. Friedmann, E. Galun, G. L. DeNardo, S. J. DeNardo, A. Casadevall, E. Dadachova, G. B. Thornton |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2013-01-01
|
Series: | Journal of Skin Cancer |
Online Access: | http://dx.doi.org/10.1155/2013/828329 |
Similar Items
-
The Depths of Knowledge
by: DeNardo, Kristin
Published: (2019) -
Gaining Insight into the Design of Oxidation Catalysts by Comparing the Rate and Equilibrium Constants That Define the Technical Performance of a Suite of TAML Activators Including Design Related Studies for Environmental Performance
by: DeNardo, Matthew A.
Published: (2016) -
Positive Allosteric Modulation of CD11b as a Novel Therapeutic Strategy Against Lung Cancer
by: Terese Geraghty, et al.
Published: (2020-05-01) -
Hexa-arginine enhanced uptake and residualization of selective high affinity ligands by Raji lymphoma cells
by: Mirick Gary, et al.
Published: (2009-04-01) -
Rethinking immune checkpoint blockade: ‘Beyond the T cell’
by: Xiuting Liu, et al.
Published: (2021-01-01)